Published online before print March 31, 2005, doi: 10.1161/01.STR.0000162751.54349.ae
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:1016.)
© 2005 American Heart Association, Inc.
Original Contributions |
Natriuretic Peptides and Mortality After Stroke
From the Graduate School of Circumpolar Wellbeing, Health, and Adaptation (A.M.M.), Centre for Arctic Medicine, University of Oulu, Finland; Biocenter (O.V.), Oulu, Finland; the Departments of Neurology (A.M.M., J.T.K., K.A.S., V.V.M.) and Physiology (O.V.) and the Department of Medicine (T.H.M., J.M.T., K.Y., H.V.H.), Division of Cardiology, University of Oulu, Oulu, Finland.
Correspondence to Anne Mäkikallio, MD, Department of Neurology, University of Oulu, Kajaanintie 50, PO Box 5000, FIN-90014 Oulu, Finland. E-mail anne.makikallio{at}mail.suomi.net
Background and Purpose— Measurement of natriuretic peptides provides prognostic information in various patient populations. The prognostic value of natriuretic peptides among patients with acute stroke is not known, although elevated peptide levels have been observed.
Methods— A series of 51 patients (mean age, 68±11years) with first-ever ischemic stroke underwent a comprehensive clinical examination and measurements of plasma atrial natriuretic peptides (N-ANP) and brain natriuretic peptides (N-BNP) in the acute phase of stroke. The patients were followed-up for 44±21 months. Risk factors for all-cause mortality were assessed. Control populations, matched for gender and age, consisted of 51 patients with acute myocardial infarction (AMI) and 25 healthy subjects.
Results— Plasma concentrations of N-ANP (mean±SD, 988±993 pmol/L) and N-BNP (751±1608 pmol/L) in the stroke patients were at the same level as those in the AMI patients (NS for both), but significantly higher than those of the healthy subjects (358±103 pmol/L, P<0.001 and 54±26 pmol/L, P<0.01, respectively). Elevated levels of N-ANP and N-BNP predicted mortality after stroke (risk ratio [RR] 4.3, P<0.01 and RR 3.9, P<0.01, respectively) and after AMI (P<0.05), and remained independent predictors of death after stroke even after adjustment for age, diabetes, coronary artery disease, and medication (RR 3.9, P<0.05 and RR 3.7, P<0.05, respectively).
Conclusion— Plasma levels of natriuretic peptides are elevated in the acute phase of stroke and predict poststroke mortality.
Key Words: natriuretic peptides • outcome • stroke
This article has been cited by other articles:
 |
|
 |
|
  A. K. Saenger and R. H. Christenson Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment Clin. Chem., January 1, 2010; 56(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Kurl, M Ala-Kopsala, H Ruskoaho, T Makikallio, K Nyyssonen, O Vuolteenaho, J Sivenius, J T Salonen, and J A Laukkanen Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men Heart, July 1, 2009; 95(13): 1067 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Whiteley, W. L. Chong, A. Sengupta, and P. Sandercock Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review Stroke, May 1, 2009; 40(5): e380 - e389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Montaner, M. Perea-Gainza, P. Delgado, M. Ribo, P. Chacon, A. Rosell, M. Quintana, M. E. Palacios, C. A. Molina, and J. Alvarez-Sabin Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers Stroke, August 1, 2008; 39(8): 2280 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF]
|
|